tiprankstipranks
Trending News
More News >
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
US Market

Rocket Pharmaceuticals (RCKT) Ownership - Who Owns Rocket Pharmaceuticals?

Compare
1,384 Followers

Rocket Pharmaceuticals (RCKT) Ownership Overview

34.67%22.53%0.51%11.37%30.92%
34.67% Insiders
0.51% Other Institutional Investors
11.37% ETFs
30.92% Public Companies and
Individual Investors
The ownership structure of Rocket Pharmaceuticals (RCKT) stock is a mix of institutional, retail, and individual investors. Approximately 34.41% of the company’s stock is owned by Institutional Investors, 34.67% is owned by Insiders, and 30.92% is owned by Public Companies and Individual Investors.
The ownership structure of Rocket Pharmaceuticals (RCKT) stock is a mix of institutional, retail, and individual investors. Approximately 23.04% of the company’s stock is owned by Institutional Investors, 34.67% is owned by Insiders, and 11.37% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 10, 2025
xxxxxxxxxxxxx
$99165
Apr 08, 2025
xxxxxxxxxxxxx
$39617
Feb 27, 2025
xxxxxxxxxxxxx
$223965
Feb 25, 2025
xxxxxxxxxxxxx
$64305

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$313030
Dec 31, 2024
xxxxxxxxxxxxx
$1220283
Dec 31, 2024
xxxxxxxxxxxxx
$4758800
Dec 31, 2024
xxxxxxxxxxxxx
$8200931

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
18,157,605Insider17.03%159,060,620
16,272,635Insider15.26%142,548,283
6,490,225Institution6.09%56,854,371
6,233,824Institution5.85%54,608,298
5,567,880Institution5.22%48,774,629
5,198,900Institution4.88%45,542,364
3,505,477Institution3.29%30,707,979
1,800,099Institution1.69%15,768,867
1,178,918Insider1.11%10,327,322
1,044,279Institution0.98%9,147,884

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,490,225Institution6.09%56,854,371
5,567,880Institution5.22%48,774,629
1,044,279Institution0.98%9,147,884
1,007,530Institution0.94%8,825,963
994,865Institution0.93%8,715,017
770,691Institution0.72%6,751,253
721,231Institution0.68%6,317,984
718,153Institution0.67%6,291,020
683,863Institution0.64%5,990,640
580,600Institution0.54%5,086,056

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,621,765Institution2.46%24,775,679
1,761,779Institution1.65%15,433,184
1,632,463Institution1.53%13,875,936
1,285,459Institution1.21%12,147,588
1,063,115Institution1.00%13,363,356
600,902Institution0.56%6,453,687
591,220Institution0.55%5,179,087
577,985Institution0.54%5,063,149
391,567Institution0.37%3,328,320
304,271Institution0.29%2,875,361

FAQ

Who Owns Rocket Pharmaceuticals (RCKT)?
According to the latest TipRanks data, approximately 0.51% of the company's stock is held by institutional investors, 34.67% is held by insiders, and 30.92% is held by retail investors.
    What percentage of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.51% of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors.
      What percentage of Rocket Pharmaceuticals (RCKT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.92% of Rocket Pharmaceuticals (RCKT) stock is held by retail investors.
        Who owns the most shares of Rocket Pharmaceuticals (RCKT)?
        RTW INVESTMENTS, LP owns the most shares of Rocket Pharmaceuticals (RCKT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis